Business ❯ Corporate Governance ❯ Shareholder Relations

Investor Rights

Class Action Participation Legal Compliance Legal Investigations Class Action Lawsuits Securities Fraud Legal Notices Litigation Support

ImmunityBio Investors Face May 26 Lead-Plaintiff Deadline in Securities Suit Tied to FDA Anktiva Rebuke

The case stems from an FDA warning that promotional claims for Anktiva were false or misleading, which drove a roughly 21% stock drop on March 24.

Stellantis Faces Securities Class Action as Investors Are Urged to Seek Lead Role

Investor Firms Step Up Bid to Lead CarMax Securities Case as Jan. 2 Deadline Looms